Market Place
Sourcing Support
Waylivra Receives Innovative Drug Category Pricing for FCS in Brazil
04 Jan 2022 //
PRNEWSWIRE
PTC Therapeutics Announces Waylivra™ Approval in Brazil
23 Aug 2021 //
PRNEWSWIRE
WAYLIVRA?, the First and Only Therapy for Familial Chylomicronaemia
09 Nov 2020 //
BUSINESSWIRE
NICE relents and okays Akcea’s rare disease drug Waylivra for NHS use
21 Sep 2020 //
PHARMA PHORUM
NICE u-turn sees Akcea`s Waylivra win NHS funding
18 Sep 2020 //
PHARMATIMES
Akcea`s WAYLIVRA® (volanesorsen) to Be Available on the NHS in England
18 Sep 2020 //
BUSINESSWIRE
Akcea Announces New Pricing and Reimbursement of WAYLIVRA®
13 Aug 2020 //
PRNEWSWIRE
Retrotope Expands its Drug Pipeline with the First Dosing of RT001
09 Jan 2020 //
GLOBE NEWSWIRE
NICE refuses Akcea’s Waylivra
04 Jan 2020 //
PHARMA TIMES
Akcea taps first commercial chief as Waylivra debuts and pipeline advances
05 Nov 2019 //
FIERCEP PHARMA
Akcea Therapeutics Appoints Chief Commercial Officer
24 Oct 2019 //
CONTRACT PHARMA
Ionis CBO takes over Akcea as CEO, CBO and COO head out the door
24 Sep 2019 //
FIERCE BIOTECH
Ionis, Akcea`s Waylivra approved in EU after FDA rejection
09 May 2019 //
FIERCE PHARMA
FDA rejects rare disease drug developed by Cambridge`s Akcea
28 Aug 2018 //
BIZ JOURNALS
FDA nixes Akcea’s volanesorsen despite favorable AdComm
28 Aug 2018 //
FIERCE BIOTECH
FDA rejects Akcea/Ionis’ rare disease drug Waylivra
28 Aug 2018 //
PHARMA TIMES
FDA Gives Thumbs-Down to Rare Disease Drug from Ionis, Akcea
28 Aug 2018 //
XCONOMY
Akcea, PTC Therapeutics Collaborate on 2 Rare Disease Drugs in Latin America
02 Aug 2018 //
PR NEWSWIRE
IONIS-HTT Rx (RG6042) Granted PRIME Designation by the EMA
02 Aug 2018 //
PR NEWSWIRE
Ionis Closes Collaboration with Biogen to Develop Drugs for Neurological Dis
05 Jun 2018 //
PR NEWSWIRE
Akcea, Ionis win over most FDA experts to their rare disease drug volanesorsen
11 May 2018 //
ENDPTS
Astellas inks deal for phase 3 inflammatory pain drug
10 May 2018 //
FIERCE BIOTECH
Ionis, Akcea team face tough questions on safety as FDA insiders volanesorsen
09 May 2018 //
ENDPTS
Swapping stock and cash, Ionis turns to closely-controlled Akcea for a deal
15 Mar 2018 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.